LUND, Sweden and MILAN, March 19, 2026 /PRNewswire/ -- Lumito AB ("Lumito") and Tethis S.p.A. ("Tethis") today announce the completion of an initial proof-of-concept study evaluating the technical ...
MILAN and TEL HASHOMER, Israel, March 10, 2025 /PRNewswire/ -- Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel's largest medical center ...
ROME and MILAN, Oct. 3, 2025 /PRNewswire/ -- The Department of Clinical and Molecular Medicine of Sapienza University of Rome (DMCM), Takis S.r.l. and Tethis S.p.A. today announce a joint initiative, ...
MILAN, April 2, 2024 /PRNewswire/ -- Tethis S.p.A., a pioneer in the development of an innovative platform for liquid biopsy testing, is pleased to announce the enrollment of the first two patients in ...
The new platform will be presented at the next EACR Liquid Biopsy conference to be held in Bergamo, Italy, on May 24th-26th, 2022 MILAN, May 16, 2022 /PRNewswire/ -- Tethis S.p.A announces the release ...
LUND, Sweden and MILAN, March 19, 2026 /PRNewswire/ -- Lumito AB ("Lumito") and Tethis S.p.A. ("Tethis") today announce the completion of an initial proof-of-concept study evaluating the technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results